AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Veradermics, Incorporated
XNYS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00Z1S1G48
138.78▲ 0.29 (0.21%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
138.49
Day's Range
134.49 – 139.93
52-Week Range
32.00 – 141.75
Volume
422.0K
Avg Volume
880.0K
Share Statistics
Shares Outstanding
Employees
21
Exchange
XNYS
Listed
2026-02-04
Share count as of August 6, 2026

Veradermics, Incorporated (MANE) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Veradermics, Incorporated (MANE)
What is Veradermics, Incorporated's Market Cap?
Veradermics, Incorporated's Market Cap is $5.8B, based on as-reported figures from SEC (XBRL) filings.
What is Veradermics, Incorporated's Enterprise Value?
Veradermics, Incorporated's Enterprise Value is $5.5B, based on as-reported figures from SEC (XBRL) filings.
What is Veradermics, Incorporated's Net Income (TTM)?
Veradermics, Incorporated's Net Income (TTM) is -$92.7M, based on as-reported figures from SEC (XBRL) filings.
What is Veradermics, Incorporated's Diluted EPS (TTM)?
Veradermics, Incorporated's Diluted EPS (TTM) is -2.22, based on as-reported figures from SEC (XBRL) filings.
What is Veradermics, Incorporated's Net Debt?
Veradermics, Incorporated's Net Debt is -$319.3M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · MANEAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income:
Interest income
Other income
Total other income, net
Loss before income taxes
Income tax benefit
Net loss
Net loss attributable to common stock, basic
Net loss attributable to common stock, diluted
Net loss per share of common stock, basic (in usd per share)
Net loss per share of common stock, diluted (in usd per share)